84 related articles for article (PubMed ID: 2293073)
1. [Assessment of the use of Pap test in a sample of pregnant women].
Dindelli M; Parazzini F; Rabaiotti E; Liati P; Ferrari A
Minerva Ginecol; 1990; 42(7-8):305-8. PubMed ID: 2293073
[TBL] [Abstract][Full Text] [Related]
2. [Knowledge and use of Pap-smear among HIV-positive women].
Pavia C; Navarra A; Pisani G; Piselli P; Koehler B; Angeletti C; Ippolito G; Serraino D
Minerva Ginecol; 2006 Jun; 58(3):233-8. PubMed ID: 16783295
[TBL] [Abstract][Full Text] [Related]
3. Educational level and cervical cancer screening programs in a Venezuelan urban area.
Núñez-Troconis J; Velásquez J; Mindiola R; Munroe D
Invest Clin; 2008 Sep; 49(3):331-9. PubMed ID: 18846774
[TBL] [Abstract][Full Text] [Related]
4. [Management of cases of abnormal cervical smear].
Presse Med; 1999 Apr; 28(13):695-9. PubMed ID: 10228482
[No Abstract] [Full Text] [Related]
5. Evaluation of cervical cancer screening program at a rural community of South Africa.
Hoque M; Hoque E; Kader SB
East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
[TBL] [Abstract][Full Text] [Related]
6. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
Nygård M; Daltveit AK; Thoresen SO; Nygård JF
BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
[TBL] [Abstract][Full Text] [Related]
7. Cervical cytology in vulnerable pregnant women.
Loomis DM; Pastore PA; Rejman K; Gutierrez KL; Bethea B
J Am Acad Nurse Pract; 2009 May; 21(5):287-94. PubMed ID: 19432913
[TBL] [Abstract][Full Text] [Related]
8. [An operative model: verification of the quality of the screening Pap test ].
Montanari GR; Arnaud S; Berardengo E; Campione D; Cozzani C; Parisio F; Viberti L; Ghiringhello B
Pathologica; 2001 Oct; 93(5):609-10. PubMed ID: 11725370
[No Abstract] [Full Text] [Related]
9. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
[TBL] [Abstract][Full Text] [Related]
10. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
[TBL] [Abstract][Full Text] [Related]
11. Knowledge and awareness of cervical cancer and screening among Malaysian women who have never had a Pap smear: a qualitative study.
Wong LP; Wong YL; Low WY; Khoo EM; Shuib R
Singapore Med J; 2009 Jan; 50(1):49-53. PubMed ID: 19224084
[TBL] [Abstract][Full Text] [Related]
12. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
13. Sentinel Pap smears in 261 invasive cervical cancer patients in Italy.
Igidbashian S; Maggioni A; Casadio C; Boveri S; Cristoforoni P; Sideri M
Vaccine; 2009 May; 27 Suppl 1():A34-8. PubMed ID: 19480959
[TBL] [Abstract][Full Text] [Related]
14. Screening for cervical disease in mature women: strategies for improvement.
Colgan TJ; Clarke A; Hakh N; Seidenfeld A
Cancer; 2002 Aug; 96(4):195-203. PubMed ID: 12209660
[TBL] [Abstract][Full Text] [Related]
15. Cervical cancer screening in a rural population of Zimbabwe.
Thistle PJ; Chirenje ZM
Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
[TBL] [Abstract][Full Text] [Related]
16. Understanding cervical cytology.
Beal MW
Nurse Pract; 1987 Mar; 12(3):8-10, 15, 18-22. PubMed ID: 3561907
[TBL] [Abstract][Full Text] [Related]
17. [Cytological study of an inflammatory type Pap-test].
Giannone R; Bernorio R; Panizzardi G; Piacezzi C; Poli M
Minerva Ginecol; 1992 Jun; 44(6):321-4. PubMed ID: 1635655
[TBL] [Abstract][Full Text] [Related]
18. Adjunctive high-risk human papillomavirus DNA testing is a useful option for disease risk assessment in patients with negative Papanicolaou tests without an endocervical/transformation zone sample.
Zhao C; Austin RM
Cancer; 2008 Aug; 114(4):242-8. PubMed ID: 18484643
[TBL] [Abstract][Full Text] [Related]
19. Women's attitudes to and awareness of smear testing and cervical cancer.
Yu CK; Rymer J
Br J Fam Plann; 1998 Jan; 23(4):127-33. PubMed ID: 9882766
[TBL] [Abstract][Full Text] [Related]
20. Improved cervical cancer screening in premenopausal women by combination of Pap smear and speculoscopy.
Twu NF; Chen YJ; Wang PH; Yu BK; Lai CR; Chao KC; Yuan CC; Yen MS
Eur J Obstet Gynecol Reprod Biol; 2007 Jul; 133(1):114-8. PubMed ID: 16797826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
